28.02.2013 Views

autologous blood and marrow transplantation - Blog Science ...

autologous blood and marrow transplantation - Blog Science ...

autologous blood and marrow transplantation - Blog Science ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

576 Chapter 10: Graft Manipulation<br />

Table 1. Neutrophil engraftment: single vs. split reinfusion<br />

Single reinfusion Split reinfusion P value<br />

Days ANC 100 11 ±2.5 9 ±0.8 0.0322<br />

Days ANC >500 13 ±2.6 11 ± 1.2 0.0168<br />

respectively (P=0.44). Administration of G-CSF 24 hours before transplant <strong>and</strong><br />

stem cell infusion over 2 days positively affected neutrophil engraftment (Table 1).<br />

The number of neutropenic days was reduced, with significantly faster myeloid<br />

engraftment. Although not statistically relevant, there was a trend toward faster<br />

platelet recovery <strong>and</strong> fewer transfusions (Table 2).<br />

In an effort to hasten platelet recovery, G-CSF administration was delayed to 48<br />

hours after completion of the split transplant instead of 24 hours before reinfusion.<br />

Results are summarized in Table 3 for platelet recovery <strong>and</strong> in Table 4 for<br />

neutrophil recovery. There was a continued trend toward faster platelet recovery.<br />

Conversely, the number of neutropenic days increased from 3 to 5 <strong>and</strong> initial<br />

myeloid engraftment to > 100 was significantly delayed.<br />

The combination of split infusion <strong>and</strong> delayed G-CSF hastened platelet<br />

recovery (Table 5) compared with our original protocol, which initiated G-CSF 24<br />

hours before a single infusion of stem cells. The improvement in platelet<br />

engraftment to 20,000 <strong>and</strong> 50,000 was both statistically <strong>and</strong> clinically relevant, as<br />

was the decrease in the number of platelet transfusions. Postponing the administration<br />

of G-CSF did not negatively impact myeloid recovery or the number of<br />

neutropenic days (Table 6) compared with the initial protocol of a single infusion<br />

preceded by G-CSF.<br />

DISCUSSION<br />

The side effects associated with stem cell reinfusion can be more severe when<br />

the cells derive from large-volume, hypercellular leukaphereses that require more<br />

DMSO for adequate cryoprotection. Reinfusion of stem cells in two sessions on<br />

consecutive days not only minimized the anticipated side effects but also had an<br />

Table 2. Platelet engraftment: single vs. split reinfusion<br />

Single reinfusion Split reinfusion P value<br />

Days platelets >20,000 22 ± 7.9 17 ±5.9 0.1077<br />

Days platelets >50,000 31 ± 14.6 21 ±8.6 0.0713<br />

No. transfusions 4.2 ±1.6 3.0 ± 1.3 0.0678

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!